Eshwar Inapuri

Eshwar Inapuri began their work experience as a Research Assistant at Michigan Medicine in 2014. In 2015, they worked as a Finance and Accounting Intern at Clark Hill PLC. Eshwar then joined the University of Pennsylvania in 2016 as a Student Researcher until 2019. In 2017, Eshwar co-founded InnaMed and served as the CEO, focusing on developing at-home blood testing technology. InnaMed was later acquired by Fluxergy in 2022. Eshwar also worked as an Advisor at Ventricle Health from September 2021 to December 2022. Currently, they are the Founding Head of Product at Ventricle Health, where they lead product development, fundraising, and supports go-to-market strategies and operations.

Eshwar Inapuri completed their primary and secondary education at Novi High School from 2011 to 2015. Following this, they enrolled at the University of Pennsylvania where they pursued a Bachelor's Degree in Bioengineering from 2015 to 2019. In 2017, Eshwar also participated in the Y Combinator W17 Cohort, although the field of study for this program is not specified.